Estimated 319,400 Deaths From Rheumatic Heart Disease in 2015

This article originally appeared here.
Share this content:
Estimated 319,400 Deaths From Rheumatic Heart Disease in 2015
Estimated 319,400 Deaths From Rheumatic Heart Disease in 2015

WEDNESDAY, Aug. 23, 2017 (HealthDay News) -- In 2015 there were an estimated 319,400 deaths due to rheumatic heart disease, with a reduction in global age-standardized mortality from 1990, according to a study published in the Aug. 24 issue of the New England Journal of Medicine.

David A. Watkins, M.D., M.P.H., from the University of Washington in Seattle, and colleagues conducted a systematic review of data on fatal and nonfatal rheumatic heart disease for 1990 to 2015. The Cause of Death Ensemble model and DisMod-MR 2.1 were used to produce estimates of mortality and prevalence.

The researchers found that there were an estimated 319,400 deaths due to rheumatic heart disease in 2015. From 1990 to 2015 there was a 47.8 percent decrease in global age-standardized mortality due to rheumatic heart disease, with large differences seen across regions. Oceania, South Asia, and central sub-Saharan Africa had the highest age-standardized mortality due to and prevalence of rheumatic heart disease in 2015. There were an estimated 33.4 million cases of rheumatic heart disease in 2015, and 10.5 million disability-adjusted life-years due to rheumatic heart disease worldwide.

"The health-related burden of rheumatic heart disease has declined worldwide, but high rates of disease persist in some of the poorest regions in the world," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »